Stanford
Metagenomic Infectious Disease Sequencing Test Repurposed for Cancer Detection From CSF Samples
Premium
The assay from a Stanford and UCSF team allows clinicians to scan for multiple cancers of the central nervous system and to reanalyze past samples.
Stanford Team Developing Metabolomic Technique to Detect Influzenza, Other Respiratory Viruses
Premium
Viruses can induce metabolite alterations that can be detected and allow for diagnosis of different infections, potentially including SARS-CoV-2.
Foresight Diagnostics Commercializing PhasED-seq Liquid Biopsy Tech for Improved MRD Detection
Premium
The technology, developed by researchers at Stanford, showed strong performance in a new study of lymphoma, and early data for solid tumors is already available.
In Brief This Week: Foundation Medicine, Myriad Genetics, Immunovia, Biocept, and More
News items for the in vitro diagnostics industry for the week of June 28, 2021.
Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech
The company, founded by Stanford University scientists, is advancing a technology called PhasED-Seq for cancer minimal residual disease detection.
Feb 11, 2021
Feb 3, 2021
Nov 18, 2019
Nov 1, 2019
Oct 31, 2019